These methods can identify tissue-specific methylation patterns that are highly enriched in cancer, such as those in SEPT9 (colorectal cancer) [39], SHOX2 (lung cancer) [40,41], and GSTP1 (prostate cancer) [42,43]. This evidence concerns the gene GSTP1 and prostate cancer.